Article
Ribavirin inhibition of cell-culture infectious hepatitis C genotype 1-3 viruses is strain-dependent.
Virology - 15 Jan 2020
Mejer Niels, Galli Andrea, Ramirez Santseharay, Fahnøe Ulrik, Benfield Thomas, Bukh Jens
Abstract excerpt
Ribavirin remains relevant for successful treatment of chronic hepatitis C virus (HCV) infections in low-income settings, as well as for therapy of difficult-to-treat HCV patients. We studied the effect of ribavirin against cell-culture adapted HCV of genotypes 1, 2 and 3, representing ~80% of global infections. TNcc(1a) was the most sensitive to ribavirin, while J6/JFH1(2a) was the most resistant. EC50s ranged...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
